Mesenchymal Stromal Cells for the Treatment of Non-union Fractures of Long Bones
A Phase IIa, Single Center, Prospective, Randomized, Parallel, Two-arms, Single-dose, Open-label With Blinded Assessor Pilot Clinical Trial to Assess ex Vivo Expanded Adult Autologous Mesenchymal Stromal Cells Fixed in Allogeneic Bone Tissue (XCEL-MT-OSTEO-ALPHA) in Non Hypertrophic Pseudoarthrosis of Long Bones
Sponsor: Banc de Sang i Teixits
Listed as NCT02230514, this PHASE1/PHASE2 trial focuses on Atrophic Nonunion of Fracture and remains completed. Sponsored by Banc de Sang i Teixits, it has been updated 12 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE1/PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
May 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
Status: Active Not Recruiting → Completed
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
▶ Show 7 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Aug 2019 — Feb 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Aug 2018 — Aug 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Aug 2017 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2017 — Aug 2017 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Nov 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Banc de Sang i Teixits
- Hospital ASEPEYO Sant Cugat
For direct contact, visit the study record on ClinicalTrials.gov .